In unimmunized specific pathogen-free mice, there are unique memory-type CD8 + T cell populations expressing asialoGM1 (ASGM1). These cells were classified into central memory-type T cells (T CMT ) judging from their expression profile of CD44, IL-2Rb, CD62L and CCR7 cell-surface molecules. Among CD44 high CD8 + so-called memory CD8
Introduction
It has been demonstrated that immune balance is controlled by cytokines derived from two distinct T h subsets, T h 1 and T h 2 (1-3). T h 1 produce IL-2 and IFN-c, while T h 2 produce IL-4, IL-5 and IL-6. The former plays a critical role in cellular immunity, while the latter is involved in humoral immunity. It has also been demonstrated that CD8
+ T cell populations are subdivided into IFN-c-producing Tc1 and IL-4-producing Tc2 cells such as T h subsets (4) (5) (6) (7) (8) (9) . More confusingly, innate effector cells such as dendritic cells (DC), NK, NKT and cd T cells produce various cytokines including T h 1 cytokines and T h 2 cytokines (2, (10) (11) (12) . Type 1 immunity is regulated by DC, macrophages (M/), NK, NKT, cd T, T h 1 and Tc1 cells which produce T h 1-inducing cytokines (e.g. IL-12, IL-18 and IFN-c), whereas type 2 immunity is regulated by DC, M/, NKT, cd T, T h 2 and Tc2 cells producing T h 2-inducing cytokines (e.g. IL-4, IL-10 and transforming growth factor-b). Thus, the immune balance is controlled by many immunoregulatory cells in addition to T h 1 and T h 2.
As reported previously, type 1 acquired immunity regulated by IFN-c-producing T h 1 and Tc1 cells is crucial for inducing protective immunity against infectious and malignant diseases, though too much acceleration is a causative of autoimmune diseases (13) (14) (15) (16) . Therefore, it is of great importance to define the early IFN-c source of immunoregulatory cells, which is beneficial for inducing Tc1-and T h 1-mediated type 1 immunity.
In the previous paper (17), we found that freshly isolated CD8 + T cells from unimmunized mice contained minor asialoGM1 + (ASGM1 + ) CD8 + T cell subsets, which exhibited augmented immune responses to 
CD8
+ T CMT compared with T h 2-prone BALB/c mice. Thus, the present data indicate the critical role of genetically controlled ASGM1 + CD8 + T CMT in the regulation of type 1 immunity, which is crucial for inducing protective immunity against infectious and malignant diseases.
Methods

Animals
Wild-type C57BL/6 and BALB/c female mice, 5-6 weeks of age, were purchased from Charles River Japan Inc. (Kanagawa, Japan). IFN-c-deficient C57BL/6 mice were kindly gifted by Y. Iwakura (Institute of Medical Science, University of Tokyo, Tokyo, Japan). All animals were housed under specific pathogen-free (SPF) conditions.
Flow cytometry
Phenotypic characterization of ASGM1
+ CD8 + T cells was analyzed by FACSCalibur (BD Biosciences, San Jose, CA, USA) using the following mAbs: PE-Cy5-anti-CD8a, PE-anti-CD44, PE-anti-CD122 (IL-2Rb), PE-anti-CD62L, PE-anti-NK1.1, PE-anti-TCRb, PE-anti-CD3e, PE-anti-CD8b.2, biotin-anti-CD44 and allophycocyanin (APC)-streptavidin. All mAbs were purchased from BD Biosciences PharMingen (San Jose, CA, USA), except PE-anti-CCR7 mAb (eBioscience, San Diego, CA, USA) and anti-ASGM1 antibody plus FITC-anti-rabbit antibody (WAKO Pure Chemical Industries, Ltd, Osaka, Japan). Samples were analyzed by CellQuest software (BD Biosciences).
Cell purification
ASGM1
+ CD8 + T cells, ASGM1 À CD8 + T cells and the other CD8 + T cell populations were separated from nylon-wool passaged spleen cells using MACS system (Miltenyi Biotec, Bergisch Glabach, Germany) and FACSVantage (BD Biosciences). For purification of naive (CD45RB + ) CD4 + T cells, selected CD4
+ T cells by MACS system were stained with PE-anti-CD4 and FITC-anti-CD45RB (BD Biosciences PharMingen) and then isolated using FACSVantage. The sorted cells were >95% pure.
In vitro stimulation and detection of IFN-c
The purified CD8 + T cell subsets were stimulated with immobilized anti-CD3 mAb or IL-2 plus IL-12 under standard culture conditions (37°C, 5% CO 2 ) on a flat-bottomed 96-well plate. Anti-CD3 mAb was purchased from BD Biosciences PharMingen. Recombinant IL-12 and IL-2 were kindly donated by Wyeth Research (Cambridge, MA, USA) and Takuko Sawada (Shionogi Pharmaceutical Institute Co. Ltd, Osaka, Japan), respectively. IFN-c and IL-4 levels in culture supernatant were measured using BD OptEIA TM ELISA kits (BD Biosciences PharMingen). IL-13 concentrations in culture supernatant were measured using Quantikine ELISA kit (R&D System, Minneapolis, MN, USA). The amount of cytokine production was calculated from the extrapolated curve of a standard graph.
Intracellular cytokine staining
For in vivo experiments, spleens were harvested at various indicated time points after anti-CD3 mAb injection and then single-cell suspensions were prepared. For in vitro experiments, CD4
+ T cells were harvested at 42 h after co-culturing with each CD8 + T population. The cells were stained with the indicated cell-surface mAbs for 15 min, washed with PBS/ 0.05% NaN 3 /0.5% BSA, fixed with 4% PFA for 15 min at 4°C and treated with permeabilizing solution (50 mM NaCl, 5 mM EDTA, 0.02% NaN 3 and 0.5% Triton X-100, pH 7.5) at 4°C followed one wash. After 10 min, these cells were washed and stained with APC-conjugated anti-IFN-c mAb (BD Biosciences PharMingen) for 45 min at 4°C. The percentage of cells producing cytoplasmic IFN-c was determined using FACSCalibur.
Statistical analyses
All experiments were repeated at least three times. Mean values and standard errors were calculated for data from three independent experiments and are shown in the figures. Significant differences in the results were determined by using the two-sided Student's t-test. P < 0.05 was considered significant in the present experiments.
Results
ASGM1
+ CD8 + T cells are T CMT expressing CD62L and CCR7 antigens
The phenotypic characteristics of ASGM1 + CD8 + T cells existed in unimmunized C57BL/6 mouse was analyzed by flow cytometry. As shown in Fig. 1 + memory T cells expressed ASGM1 (Fig. 1B) . Moreover, it was demonstrated that ASGM1
+ CD8 + T cells also expressed CD122 (IL-2Rb), CD62L and CCR7 cell-surface molecules, and there was no significant levels of NK1.1 expression on these cells (Fig. 1C) . Thus, consistent with our previous report (18) , these results suggested that ASGM1 + CD8 + T cells were defined as T CMT . Because we isolated ASGM1 + CD8 + T cells from unimmunized naive C57BL/6 mice and the number of them greatly reduced in Rag2
À/À ovalbumin peptide-specific TCR-transgenic mice (OT-1 Rag2 À/À mice) (18), these ASGM1 + CD8 + T CMT were probably induced by homeostatic expansion mechanisms in peripheral lymphoid organs, involving expansion of T cells recognizing self-MHC/peptide or intestinal flora antigen.
+ CD8 + T CMT are responsible for IFN-c production among CD44 high CD8 + memory T cell population + T cell populations was cultured with immobilized anti-CD3 mAb for 48 h and IFN-c and IL-4 activity in culture supernatants were measured by ELISA. There was no IL-4 production, which was crucial for T h 2 immunity, from each population (data not shown). In Fig. 2 + T cells (Fig. 3) . There was no significant difference in the expression levels of CD8b, indicating that ASGM1 + CD8 + T CMT expressed the CD8ab heterodimer. Quantitative and qualitative differences of ASGM1 + CD8 + T CMT between T h 1-prone C57BL/6 and T h 2-prone BALB/c mice During investigating the frequency of ASGM1 + CD8 + T CMT , we found that C57BL/6 mice possessed higher frequency of ASGM1 + CD8 + T CMT in CD8 + T cells compared with that of BABL/c mice. As shown in Fig. 6(A (Fig. 6B) or anti-CD3 mAb stimulation (Fig. 6C) . However, BALB/c-derived ASGM1 + CD8 + T CMT enriched by sorting showed very low IFN-c production in response to IL-2 plus IL-12 or anti-CD3 mAb stimulation. Here, even in the case of ASGM1 + CD8 + T CMT from T h 2-prone BALB/c mice, there was no IL-4 and IL-13 production, which may interfere IFN-c production from T h in the same experiments ( Fig. 6C and data not shown) . Therefore, the differentiation of ASGM1 + CD8 + T CMT in vivo appeared to be controlled by some unknown genetic factors.
Discussion
In this study, we showed that ASGM1 (19, 20, 25) . However, in the present work, we used unimmunized C57BL/6 mice. As reported previously, even in unimmunized naive mice maintained under SPF conditions, there are small percentage of memory T cells, which may be derived from thymus-derived naive T cells by peripheral homeostatic expansion mechanisms receiving unknown self-antigen stimulation, and these memory-type CD8 + T cells convert to phenotypic, functional and gene expression characteristics similar to those of 'true' memory T cells (21) (22) (23) (24) (25) . Although it has been recently reported that CD8 + NKT cells have the potential of immediate antigen-specific effector functions, ASGM1 + CD8 + T CMT seemed to be distinct from CD8 + NKT cells in terms of their cell surface phenotype (26) and freshly isolated ASGM1 + CD8 + T CMT showed <2% cytotoxicity against YAC-1 cells at 20:1 effector-target (E/T) ratio (data not shown).
In the previous paper (27) , we demonstrated that CD45RB À CD62L À CD4 + memory T cells induced by homeostatic expansion produced higher levels of IL-4 and IL-10 to regulate 
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T h 1-T h 2 immune responses. In this paper, we defined novel ASGM1 + CD8 + T CMT , which might be involved in regulation of type 1-type 2 immune balance without IL-4 and IL-13 production. During the differentiation of naive CD4
+ T cells into a T h 1 or a T h 2 phenotype, many factors influence the T h lineage commitment, including cytokines, transcription factors, dose of antigens and co-stimulatory pathways (3, 28, 29) . However, the cytokine environment is generally considered to be the most potent inducer of T h 1-T h 2 fate, and the critical factors are IL-12 to promote T h 1 and IL-4 to induce T h 2. Moreover, IFN-c has been shown to enhance the differentiation of CD4 + T cells into T h 1 phenotype (30) (31) (32) . Although it had been well known that NK and NKT cells were the major source of early IFN-c upon activation, we demonstrated that ASGM1 + CD8 + T CMT also produced early IFN-c (Figs 2 and  4) . Furthermore, when naive CD4 + T h were co-cultured with wild-type ASGM1 +
CD8
+ T CMT under TCR stimulation, they differentiated into IFN-c-producing T h (Fig. 5) , though they had no differentiation in the presence of IFN-c-deficient ASGM1 + CD8 + T CMT . These results suggest that IFN-cproducing ASGM1 +
+ T CMT have the ability to promote T h 1 polarization and contribute to immune responses.
T h phenotype development is controlled not only by cytokines but also by the other factors including genetic background and classical examples of mice strains are T h 1-prone C57BL/6 and T h 2-prone BALB/c mice. Our results revealed that both the proportion and the functional property of ASGM1 + CD8 + T CMT were genetically controlled between C57BL/6 and BALB/c mice. In both strains, ASGM1 + CD8 + T CMT had similar surface phenotype in the expression of CD44, CD122, CD62L and CCR7, indicative of a central memory phenotype (data not shown). However, the proportion of ASGM1 + subset in CD8 + T cells was ;3-fold higher in C57BL/6 mice in comparison to BALB/c mice (Fig. 6A) . In addition, ASGM1
+ CD8 + T CMT from C57BL/6 mice produced a large amount of IFN-c than that from BALB/c mice in response to IL-2 plus IL-12 stimulation (Fig. 6B) or immobilized anti-CD3 mAb (Fig. 6C) . In both strains of mice, there was no IL-4 and IL-13 production by ASGM1 + CD8 + T CMT following anti-CD3 stimulation (Fig. 6C and data not shown) . We have also identified two suggestive quantitative trait loci that influence the proportion of ASGM1 + CD8 + T cells: IL-1a [logarithm of odds (LOD) 2.2, P ¼ 0.0016] and D2Mit62 (LOD 2.1, P ¼ 0.0021) on chromosome 2 at 73 and 65 cM, respectively, using the 13 CXB recombinant inbred mouse strains derived from BALB/c and C57BL/6 progenitors and linkage analysis by Map Manager QTb29 software [(33) and data not shown]. These results suggest that the differences of ASGM1 + CD8 + T CMT in not only the frequency but also the capacity to produce IFN-c may, at least in part, account for the differences in immune response between T h 1-type C57BL/6 and T h 2-type BALB/c mice.
Recent works have suggested that CD8 + T cells produce IFN-c rapidly in response to cytokines such as IL-12 or IL-18 from antigen-stimulated DC or M/ (34-38), indicating that IFN-c production of CD8 + T cells is important for the initiation of early immunoregulation. Moreover, it was shown that T CM were superior to T EM in conferring protective immunity against viral or bacterial challenge, and established tumor (19, 25, (39) (40) (41) . The evidence that ASGM1 antigen is selectively expressed on IL-12-responding pre-killer T cells producing IFN-c (17) and early IFN-c producers upon TCR stimulation indicates that ASGM1 antigen combined with CD62L and CCR7 may become a good marker to isolate great precursor cells for IFN-c-producing Tc1 cells with cytotoxic activity.
We have already demonstrated that ASGM1 + CD8 + T CMT were also differentiated into IFN-c-high-producing CTLs in response to type 1 IFNs in addition to anti-CD3 mAb or IL-12 stimulation (D. Wakita et al., unpublished data). Therefore, it is possible to speculate that ASGM1 +
+ T CMT directly differentiated into IFN-c-producing CTLs in response to IL-12 and/or type 1 IFNs produced by innate effector cells such as DC and M/ activated with pathogenic antigens. Alternatively, ASGM1 +
+ T CMT may indirectly play a critical role in the regulation of T h 1 immunity as early IFN-c-producing CD8 + T cells. In addition, we have also shown that allospecific CTLs were efficiently generated from ASGM1 + CD8 + T CMT but not from ASGM1 À CD8 + T cells (data not shown). Moreover, in CpG-based tumor vaccine therapy model, we previously demonstrated that depletion of ASGM1 + CD8 + T CMT caused the inhibition of the generation of tetramerpositive tumor-specific CD8 + CTLs and anti-tumor activity (D. Wakita et al., unpublished data). However, such inhibition was not observed when NK and NKT cells were depleted by treatment with anti-NK1.1 mAb (42) . Taken together, these observations suggest that ASGM1 + CD8 + T cells appear to be a precursor of antigen-specific CTLs. We are now investigating the precise role of ASGM1 + CD8 + T CMT in the integration between innate and acquired T cell immunity during regulation of type 1 immune balance, which is crucial for inducing anti-tumor immunity. 
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